Nathan Rich

Stock Analyst at Goldman Sachs

(0.94)
# 2052
Out of 5,333 analysts
96
Total ratings
44.68%
Success rate
3.99%
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
OSCR Oscar Health
Maintains: Neutral
16 21
17.09 22.88% 6 May 9, 2024
ZTS Zoetis
Maintains: Buy
223 196
159.31 23.03% 8 May 6, 2024
XRAY Dentsply Sirona
Maintains: Neutral
34 30
15.82 89.63% 8 May 6, 2024
AMRX Amneal Pharmaceutica...
Maintains: Strong Buy
7 8
7.43 7.67% 7 May 6, 2024
NVST Envista Holdings
Maintains: Sell
20 18
17.61 -0.62% 4 May 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
450 385
249.47 54.33% 7 Apr 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
13 14
11.96 17.06% 9 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
10 11
16.93 -35.03% 4 Feb 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
197 225
181.81 23.76% 2 Feb 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
500 650
491.88 32.15% 3 Jan 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
35 30
n/a n/a 4 Dec 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
350 300
n/a n/a 8 Nov 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
100 88
66.93 31.48% 6 May 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 12
15.13 -20.69% 6 Apr 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
93 85
68.67 23.78% 1 Jul 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
18 16
n/a n/a 1 May 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
10 11
8.76 25.57% 3 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
280 240
n/a n/a 3 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
335
322.53 3.87% 1 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
535
380.46 40.62% 4 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
10
n/a n/a 1 Dec 18, 2019